BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32651697)

  • 1. Prognostic Factors for Surgically Resected Intraductal Papillary Neoplasm of the Bile Duct: A Retrospective Cohort Study.
    Uemura S; Higuchi R; Yazawa T; Izumo W; Matsunaga Y; Shiihara M; Ota T; Furukawa T; Yamamoto M
    Ann Surg Oncol; 2021 Feb; 28(2):826-834. PubMed ID: 32651697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung metastases from intraductal papillary neoplasm of the bile duct: a case report.
    Fujino R; Masuoka Y; Mashiko T; Nakano A; Hirabayashi K; Nakagohri T
    World J Surg Oncol; 2020 Oct; 18(1):271. PubMed ID: 33097064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term clinical outcome of the surgically resected intraductal papillary neoplasm of the bile duct.
    Jung G; Park KM; Lee SS; Yu E; Hong SM; Kim J
    J Hepatol; 2012 Oct; 57(4):787-93. PubMed ID: 22634127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraductal papillary neoplasm of the bile duct: Assessment of invasive carcinoma and long-term outcomes using MRI.
    Lee S; Kim MJ; Kim S; Choi D; Jang KT; Park YN
    J Hepatol; 2019 Apr; 70(4):692-699. PubMed ID: 30553839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of surgery for 2010 WHO classification-based intraductal papillary neoplasm of the bile duct: Case-control study of a single Japanese institution's experience with special attention to mucin expression patterns.
    Harada F; Matsuyama R; Mori R; Kumamoto T; Morioka D; Taguri M; Yamanaka S; Endo I
    Eur J Surg Oncol; 2019 May; 45(5):761-768. PubMed ID: 30389302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence After Resection for Intraductal Papillary Neoplasm of Bile Duct (IPNB) According to Tumor Location.
    You Y; Choi SH; Choi DW; Heo JS; Han IW; Jang KT; Han S
    J Gastrointest Surg; 2020 Apr; 24(4):804-812. PubMed ID: 31062272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of surgical resection for intraductal papillary neoplasm of the bile duct.
    Luvira V; Pugkhem A; Bhudhisawasdi V; Pairojkul C; Sathitkarnmanee E; Luvira V; Kamsa-Ard S
    J Gastroenterol Hepatol; 2017 Feb; 32(2):527-533. PubMed ID: 27356284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Tumor Location on Postoperative Outcome of Intraductal Papillary Neoplasm of the Bile Duct.
    Matsumoto T; Kubota K; Hachiya H; Sakuraoka Y; Shiraki T; Shimizu T; Mori S; Iso Y; Kato M; Yamagishi H; Imai Y; Aoki T
    World J Surg; 2019 May; 43(5):1313-1322. PubMed ID: 30659344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-grade dysplasia/carcinoma in situ of the bile duct margin in patients with surgically resected node-negative perihilar cholangiocarcinoma is associated with poor survival: a retrospective study.
    Higuchi R; Yazawa T; Uemura S; Izumo W; Furukawa T; Yamamoto M
    J Hepatobiliary Pancreat Sci; 2017 Aug; 24(8):456-465. PubMed ID: 28547855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CK20 and lymph node involvement predict adverse outcome of malignant intraductal papillary neoplasm of the bile duct.
    Shi J; Wan X; Xie Y; Lin J; Long J; Xu W; Liang Z; Sang X; Zhao H
    Histol Histopathol; 2020 May; 35(5):449-456. PubMed ID: 31657857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic characteristics and long-term prognosis of intraductal papillary neoplasm of the bile duct: a retrospective study.
    Wu X; Li B; Zheng C
    Eur J Med Res; 2023 Mar; 28(1):132. PubMed ID: 36945047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological Features and Long-Term Outcomes of Intraductal Papillary Neoplasms of the Bile Duct of the Liver: Single-Institution Experience with 146 Patients.
    Youn JM; Hwang S; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Hong SM
    J Gastrointest Surg; 2022 Jul; 26(7):1394-1405. PubMed ID: 35141839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic analysis of intraductal papillary neoplasm of bile duct: Korean multicenter cohort study.
    Kim JR; Jang KT; Jang JY; Lee K; Kim JH; Kim H; Kim SW; Kwon W; Choi DW; Heo J; Han IW; Hwang S; Kim WJ; Hong SM; Kim DS; Yu YD; Kim JY; Nah YW; Park HW; Choi HJ; Han HS; Yoon YS; Park SJ; Hong EK; Seo HI; Park DY; Kang KJ; Kang YN; Yu HC; Moon WS; Lim CS; Bae JM; Jo S; Lee W; Roh YH; Jeong JS; Jeong CY; Lee JS; Song IS; Kim KH; Kim HG; Cho CH; Joo SH; Won KY; Kim HJ; Choi JH; Chu CW; Lee JH; Park IY; Lee H; Lee SE; Kim HS; Lee HK; Cho MS; Kim H; Han KM
    HPB (Oxford); 2020 Aug; 22(8):1139-1148. PubMed ID: 31837945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological characteristics of intraductal papillary neoplasm of the bile duct: a Japan-Korea collaborative study.
    Kubota K; Jang JY; Nakanuma Y; Jang KT; Haruyama Y; Fukushima N; Furukawa T; Hong SM; Sakuraoka Y; Kim H; Matsumoto T; Lee KB; Zen Y; Kim J; Miyazaki M; Choi DW; Heo JS; Endo I; Hwang S; Nakamura M; Han HS; Uemoto S; Park SJ; Hong EK; Nanashima A; Kim DS; Kim JY; Ohta T; Kang KJ; Fukumoto T; Nah YW; Seo HI; Inui K; Yoon DS; Unno M
    J Hepatobiliary Pancreat Sci; 2020 Sep; 27(9):581-597. PubMed ID: 32511838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of macroscopic morphology, multifocality, and mucin secretion on survival outcome of intraductal papillary neoplasm of the bile duct.
    Kang MJ; Jang JY; Lee KB; Han IW; Kim SW
    J Gastrointest Surg; 2013 May; 17(5):931-8. PubMed ID: 23371308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Planned limited resection of the extrahepatic bile duct in a case of intraductal papillary neoplasm of the bile duct based on preoperative examinations.
    Nanashima A; Imamura N; Hiyoshi M; Hamada T; Yano K; Wada T; Kawakami H; Ban T; Kubota Y; Sato Y; Harada K
    Clin J Gastroenterol; 2020 Apr; 13(2):233-239. PubMed ID: 31598905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent intraductal papillary neoplasm of the bile duct due to intraductal dissemination: a case report and literature review.
    Nakayama Y; Tomino T; Ninomiya M; Minagawa R; Oshiro Y; Izumi T; Taniguchi D; Hirose K; Kajiwara Y; Minami K; Nishizaki T
    Surg Case Rep; 2021 Nov; 7(1):238. PubMed ID: 34739634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is a specific T classification needed for extrahepatic intraductal papillary neoplasm of the bile duct (IPNB) type 2 associated with invasive carcinoma?
    Mitake Y; Onoe S; Igami T; Mizuno T; Yamaguchi J; Sunagawa M; Watanabe N; Kawakatsu S; Shimoyama Y; Ebata T
    J Hepatobiliary Pancreat Sci; 2023 Jun; 30(6):745-754. PubMed ID: 36349508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological features of "intraductal papillary neoplasm of the bile duct" and patient outcome after surgical resection.
    Nanashima A; Kinoshita N; Nakanuma Y; Zen Y; Sumida Y; Abo T; Hidaka S; Takeshita H; Yasutake T; Hayashi T; Nagayasu T
    Hepatogastroenterology; 2008; 55(85):1167-73. PubMed ID: 18795651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological features and prognosis of mucin-producing bile duct tumor and mucinous cystic tumor of the liver: a multi-institutional study by the Japan Biliary Association.
    Kubota K; Nakanuma Y; Kondo F; Hachiya H; Miyazaki M; Nagino M; Yamamoto M; Isayama H; Tabata M; Kinoshita H; Kamisawa T; Inui K
    J Hepatobiliary Pancreat Sci; 2014 Mar; 21(3):176-85. PubMed ID: 23908126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.